Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
4.610
-0.140 (-2.95%)
At close: Aug 13, 2025, 4:00 PM
4.810
+0.200 (4.34%)
After-hours: Aug 13, 2025, 7:55 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $27.15 million as of August 13, 2025. Its market cap has increased by 233.05% in one year.
Market Cap
27.15M
Enterprise Value
27.13M
1-Year Change
233.05%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $27.15M, a decrease of -73.77%. That is a compound annual growth rate of -24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 27.98M | 10.72% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.76B |
| Johnson & Johnson | 414.55B |
| AbbVie | 350.34B |
| UnitedHealth Group | 236.59B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.36B |
| Novo Nordisk | 222.88B |